1[1]Safety monitoring of medicinal products:guidelines for setting up and running a pharmacovigilance centre.Uppsala[S],Uppsala Monitoring Centre,2000 (reproduced in Part Ⅱ of this publication).
2[2]US report calls for tighter controls on complementary medicine[J].British Medical Journal,2002,324:870.
3[3]Three out of four Germans have used complementary or natural remedies[J].British Medical Journal,2002,325:990.
4[4]General guidelines for methodologies on research and evaluation of traditional medicine[S].Geneva,World Health Organization,2000 (WHO/EDM/TRM/2000.1).
5[5]The importance of pharmacovigilance:safety monitoring of medicinal products[M].Geneva,World Health Organization,2002.
6[6]Bowdler J.Effective communications in pharmacovigilance:the Erice report[M].Birmingham,W Lake,1997.
7[7]WHO guidelines on good agricultural and collection practices (GACP) for medicinal plants[S].Geneva,World Health Organization,2003.
8[8]Current challenges in pharmacovigilance:pragmatic approaches.Report of CIOMS Working Group V[S].Geneva,The Council for International Organizations of Medical Sciences,2001.
9[9]Guidelines for good clinical practice (GCP) for trials on pharmaceutical products.In:The use of essential drugs[S].Sixth report of the WHO Expert Committee.Geneva,World Health Organization,1995,Annex 3 (WHO Technical Report Series,No.850).
10[10]WHO Drug Dictionary[EB].Uppsala,Uppsala Monitoring Centre (electronic database,updated quarterly; information available at http//www.umc-products.com/)
